Vitamin D3 for Life

Live Enlightened

Article

Why Similar Vitamin D Levels Can Produce Different Biological Responses: Study Summary

Previous related pageWhy Similar Vitamin D Levels Can Produce Different Biological Responses: Full StudyNext related pageWhy Vitamin D Is Misinterpreted
Study at a glance

Why can similar vitamin D blood levels have different effects?

This page summarises evidence about why people with similar vitamin D blood levels can respond differently. The usual test measures 25-hydroxyvitamin D, shortened to 25(OH)D. It describes vitamin D status, but it does not directly measure every process that follows inside tissues.

Why can the body’s response to vitamin D differ?

Proteins carry vitamin D through blood, and tissues differ in how they take it up. Cells then control how much becomes active and how quickly it is broken down. They also need working vitamin D receptors, structures that receive chemical signals. Differences in these steps can change the response even when measured blood levels are similar.

What did studies in people find about vitamin D responses?

In one intervention study, healthy adults differed in blood measurements and changes inside cells after vitamin D3 exposure. Researchers used these measurements to describe high, middle and low responses. Related research found changes in how accessible DNA was to the machinery controlling genes. These results concern particular measured responses, rather than one measure of every vitamin D effect.

How much did genetics explain the rise in vitamin D levels?

A separate randomised trial found that common genetic differences affected the rise in 25(OH)D after supplements. The effects did not fully determine a person’s response. Starting vitamin D levels, body composition, environment and whether supplements were taken as planned also mattered. The main conclusion is that blood testing remains useful, while biological responses depend on additional factors.

Read the full article below ↓

Similar serum 25-hydroxyvitamin D [25(OH)D] concentrations do not guarantee identical vitamin D biology. The measured value reflects circulating status, but downstream response also depends on binding and transport, local activation by CYP27B1, degradation through CYP24A1, vitamin D receptor signalling, tissue context, genetics and the biological endpoint being measured. These modifiers help explain why two people with comparable blood results can still differ in molecular or physiological response. For the complete evidence treatment, see Why Similar Vitamin D Levels Can Produce Different Biological Responses: Full Study.

The circulating concentration is only one layer

Most 25(OH)D is carried by vitamin D-binding protein, and tissues differ in how metabolites are delivered and taken up. The precursor must then be activated, regulated and interpreted through cellular signalling. That means a similar total serum concentration does not establish identical tissue exposure or identical active-hormone signalling. The distinction is part of Vitamin D Status vs Vitamin D Effect.

Activation, degradation and receptor biology can modify response

CYP27B1 converts 25(OH)D to 1,25-dihydroxyvitamin D, while CYP24A1 participates in inactivation and degradation. Their regulation differs between tissues. Even when active hormone is present, the receiving cell must express a competent vitamin D receptor and the necessary regulatory machinery. Vitamin D Receptor Sensitivity and Density therefore represents one important layer of inter-individual and tissue-specific variation.

Human studies demonstrate personalized response patterns

In the VitDbol intervention study, healthy adults showed substantial variation in vitamin D metabolite, PTH and molecular responses after vitamin D₃ exposure. Participants could be grouped into high, mid and low responders using the study’s response measures. Related epigenomic work showed that vitamin D supplementation can alter chromatin accessibility in vivo. These findings support the broader concept of Vitamin D Response: equal exposure or similar measured status need not produce identical downstream change.

Genetics contributes but does not determine the outcome

A randomized trial found that common variants near CYP2R1, CYP24A1 and VDR modified the increase in serum 25(OH)D after vitamin D₃ supplementation. Variants in GC and CYP2R1 were also associated with baseline concentrations. These effects support a genetic contribution to response variability, but they were not large enough to justify treating genotype as destiny. Environment, body composition, baseline status, adherence and tissue context also matter.

Bottom line

A serum 25(OH)D result remains useful for describing vitamin D status, but it cannot encode every downstream determinant of biological effect. Similar measured levels can coexist with different metabolite handling, receptor signalling and molecular responses. The correct interpretation is therefore layered: measure status with an appropriate biomarker, then recognise that functional outcome depends on physiology beyond the number.

Primary scientific sources and publication details

Seuter S, Virtanen JK, Nurmi T, et al. Molecular evaluation of vitamin D responsiveness of healthy young adults. Journal of Steroid Biochemistry and Molecular Biology. 2017;174:314-321. PMID: 27282116.

Barry EL, Rees JR, Peacock JL, et al. Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial. Journal of Clinical Endocrinology & Metabolism. 2014;99(10):E2133-E2137. PMCID: PMC4184076.

Carlberg C, Seuter S, Nurmi T, et al. In vivo response of the human epigenome to vitamin D: A Proof-of-principle study. Journal of Steroid Biochemistry and Molecular Biology. 2018;180:142-148. PMID: 29317287.

Related reading

Library

Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy

The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.

Original paper ↗Read more →

Original sources

Source

Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial

Published in Journal of Clinical Endocrinology & Metabolism (2014).

Publication details

Barry EL, Rees JR, Peacock JL, et al. Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial. Journal of Clinical Endocrinology & Metabolism. 2014;99(10):E2133-E2137. PMCID: PMC4184076.

Read more →